Skip to main content
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America logoLink to Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
. 2021 Oct 26;73(10):1950. doi: 10.1093/cid/ciab802

Corrigendum to: Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial

Katherine Theiss-Nyland 1,#,, Mila Shakya 2,#, Rachel Colin-Jones 3, Merryn Voysey 4, Nicola Smith 5, Abhilasha Karkey 6, Sabina Dongol 7, Dikshya Pant 8, Yama G Farooq 9, Olga Mazur 10, Christopher Darlow 11, Kathleen M Neuzil 12, Shrijana Shrestha 13, Buddha Basnyat 14, Andrew J Pollard 15
PMCID: PMC8824803  PMID: 34698813

In the originally published version of this manuscript [Theiss-Nyland K, Cole RS, Westreich D, et al. Assessing the Impact of a Vi-polysaccharide Conjugate Vaccine in Preventing Typhoid Infections Among Nepalese Children: A Protocol for a Phase III, Randomized Control Trial. Clin Infect Dis;68(14):S67-S73. https://doi.org/10.1093/cid/ciy1106], the authors Olga Mazur and Christopher Darlow were erroneously excluded from the author list. The correct author list is as follows:

Katherine Theiss-Nyland,1,a Mila Shakya,2,a Rachel Colin-Jones,1 Merryn Voysey,1 Nicola Smith,1 Abhilasha Karkey,2 Sabina Dongol,2 Dikshya Pant,2 Yama G. Farooq,1 Olga Mazur,1 Christopher Darlow,1 Kathleen M. Neuzil,3 Shrijana Shrestha,4 Buddha Basnyat,2 and Andrew J. Pollard1

1Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom; 2Oxford University Clinical research Unit – Nepal, Patan Hospital, Kathmandu, Nepal; 3Center for Vaccine Development and Global Health, University of Maryland, Baltimore, MD, USA; 4Paediatric Research Unit, Patan Hospital, Kathmandu, Nepal

aK. T.-N. and M. S. contributed equally to this work.

The authors regret this error. The original article has not been changed to preserve the academic version of record.

Contributor Information

Katherine Theiss-Nyland, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Mila Shakya, Oxford University Clinical research Unit – Nepal, Patan Hospital, Kathmandu, Nepal.

Rachel Colin-Jones, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Merryn Voysey, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Nicola Smith, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Abhilasha Karkey, Oxford University Clinical research Unit – Nepal, Patan Hospital, Kathmandu, Nepal.

Sabina Dongol, Oxford University Clinical research Unit – Nepal, Patan Hospital, Kathmandu, Nepal.

Dikshya Pant, Oxford University Clinical research Unit – Nepal, Patan Hospital, Kathmandu, Nepal.

Yama G Farooq, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Olga Mazur, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Christopher Darlow, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.

Kathleen M Neuzil, Center for Vaccine Development and Global Health, University of Maryland, Baltimore, MD, USA.

Shrijana Shrestha, Paediatric Research Unit, Patan Hospital, Kathmandu, Nepal.

Buddha Basnyat, Oxford University Clinical research Unit – Nepal, Patan Hospital, Kathmandu, Nepal.

Andrew J Pollard, Oxford Vaccine Group, Department of Paediatrics, University of Oxford, United Kingdom.


Articles from Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America are provided here courtesy of Oxford University Press

RESOURCES